10 reports

Breast-feeding, multiple pregnancies, oral contraceptives and early age at first birth seem to reduce the risk of ovarian cancer.

  • Health Services
  • Hospital
  • Obesity
  • World
  • Forecast
  • 8.1 References

Semaglutide, a Once-Weekly Human GLP-## Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/ Levonorgestrel.

  • Obesity
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • UNNAMED
  • OBESITY: MICROBIOME THERAPEUTICS PIPELINE

One Way Liver ##.

  • Obesity
  • United States
  • Enterome Bioscience SA
  • MicroBiome Therapeutics LLC
  • Seres Therapeutics, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Eating Disorder
  • Obesity
  • Pharmaceutical
  • Shire plc

The prominent features of this report are - ##.

  • Clinical Trial
  • Obesity
  • World
  • Product Initiative
  • Shire plc
  • OBESITY - PIPELINE BY HYUNDAI PHARMACEUTICAL CO LTD, H1 2018
  • BIOLOGICS FOR OBESITY

Hyundai Pharma also offers ETC products in the therapeutic areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases.

  • Obesity
  • Research And Development
  • United States
  • Company
  • Product Initiative

It also offers contraceptive agents, chemotherapeutics, and other products.

  • Musculoskeletal Disorder
  • Obesity
  • Oncology
  • Company
  • Product Initiative
  • DYSLIPIDEMIA - PIPELINE BY HANDOK INC, H2 2018
  • Indication Name

Hyundai Pharma offers ETC products such as minopecia, cotareg, tareg, xilep xl, xilep, alcefin tablets and others in the therapeutic areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases.

  • Obesity
  • United States
  • Company
  • Product Initiative
  • Amarin Corporation plc
  • OBESITY - PIPELINE BY HANMI PHARMACEUTICALS CO LTD, H2 2017
  • OBESITY - PIPELINE BY HYUNDAI PHARMACEUTICAL CO LTD, H2 2017

Hyundai Pharma also offers ETC products in the areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases.

  • Obesity
  • Pathology
  • Pharmaceutical
  • Therapy
  • Omeros Corporation
  • OBESITY - PIPELINE BY HYUNDAI PHARMACEUTICAL CO., LTD., H2 2016
  • OBESITY - PIPELINE BY OREXIGEN THERAPEUTICS, INC., H2 2016

It also offers ETC products in the areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases.

  • Obesity
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative